BEVERLY, Mass. — LexaGene Holdings Inc. (OTCQB:LXXGF) (TSX-V:LXG) (the “Company”), a biotechnology company that develops instrumentation for pathogen detection, announced today that it has entered into a collaborative agreement with Texas A&M Veterinary Medical Diagnostics Laboratory. Under this agreement, Texas A&M will provide canine urine samples to LexaGene for testing on the Company’s LX6 prototype for […]
Databricks Helps Turn Clinical and Genomic Big Data into Insights to Improve Patient Lives Unified Analytics Platform for Genomics Enables Healthcare and Life Sciences Organizations to Obtain Insights up to 100x Faster than Existing Solutions San Francisco, CA – Databricks, the leader in unified analytics and founded by the original creators of Apache Spark™, today introduced […]
Standardizing human sample identification using automated genomic microfluidic systems that reduce hands-on time and cost per sample SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today announced the introduction of the Advanta™ Sample ID Genotyping Panel for the identification and quality assessment of human samples and cell lines in disease research. Maintaining accurate chain-of-custody from sample acquisition to data […]
õHelsinki – MediSapiens, a leading developer and provider of genomic, biomedical and healthcare data solutions, has announced today the launch of Genius™, a genomics data management and querying solution that combines population-scale scalability, ultra-high performance and cost-efficiency. The cloud-based solution enables, for the first time on the market, working with massive genomic datasets in real-time while […]
NanoString’s PanCancer IO 360 panel will be used for characterization of immune activity and development of potentially predictive gene signatures in NCI-sponsored trials SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced a collaboration with the Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI) […]
ANDE Corporation’s Rapid DNA Identification System First to Receive FBI Approval Under New Standards
Milestone marks major step toward use of Rapid DNA in police booking stations to dramatically reduce violent crime WALTHAM, MA and LONGMONT, CO – ANDE® Corporation today announced that its ANDE Rapid DNA™ Identification System has received National DNA Index System (NDIS) approval from the Federal Bureau of Investigation (FBI). The approval allows accredited NDIS […]
(openPR) – ABP Biosciences invents, develops, and markets innovative products and technologies to scientists engaged in life sciences research, diagnostic R&D, and drug discovery. ABP specializes in the area of fluorescence labeling and detection technologies. MoBiTec GmbH began offering fluorescent reagents more than 20 years ago as the first officially authorized importer of Molecular Probes […]
Agilent Technologies, Inc. (NYSE: A) today announced that it has completed the acquisition of Advanced Analytical Technologies, Inc. (AATI), a provider of capillary electrophoresis-based (CE) solutions for fully-automated analysis of a range of molecules for $250 million in cash. This acquisition brings together two innovators in the electrophoresis space. Advances in genomics, metabolomics, and proteomics […]
● Introduces pipeline to reach patients more quickly with next-generation sequencing for cancer, in line with modernized regulatory approach from the U.S. Food and Drug Administration ● Announces partnership with Freenome to accelerate companion diagnostics development in immuno-oncology by combining industry-leading artificial intelligence with QIAGEN’s Sample to Insight solutions ● Showcases QIAGEN’s NGS technologies, including […]
Dublin/Ireland and Reutlingen/Germany – ERS Genomics, NMI Natural and Medical Sciences Institute at the University of Tübingen and its affiliate NMI TT Pharmaservices today announced a patent license agreement, under which NMI and NMI TT Pharmaservices gain non-exclusive access to ERS Genomics’ CRISPR/Cas9 patents to expand their custom cell-based research service offerings. ERS Genomics holds rights […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
